The role of medicinal products in the treatment of inflammatory bowel diseases (IBD) through inhibition of TLR4/NF‐kappaB pathway

Citations Over TimeTop 10% of 2020 papers

Abstract

Inflammatory bowel disease (IBD) is a lifelong and recurrent disease of the gastrointestinal tract that afflicts many people in the world. Growing evidence has currently indicated that dysfunction of immune system, particularly toll-like receptors 4 (TLR4) signaling pathway dysfunction plays a pivotal part in the pathogenesis of IBD. TLR4 signaling is involved both in the pathogenesis and in the efficacy of treatment of IBD. There are some medicinal products and herbal medicines, which their role in the treatment of IBD through modulation of TLR4 signaling has been implicated. The purpose of this review article is to summarize those medicinal products and herbal medicines.

Related Papers

• → [Interaction between NOD-like receptor protein 3 inflammatory corpuscles and mitochondrial dysfunction in the pathogenesis of septic cardiomyopathy].(2024)1 cited
• Exploration on relationship of basic pathogenesis and disease symptom(2010)
• Discussion on pathogenesis levels of hypertension(2007)
• Analysis of Pathogenesis and Correlative Factors of Acute Upper Gastrointestinal Hemorrhage(2013)
• Update on pathogenesis in idiopathic inflammatory myopathies(2005)